EV/EBITDA
-19.39
-1.49-8.32%
95 min ago
Summary
- As of March 13, 2025, SPRY EV/EBITDA is -19.39, with a fall of -1.49 (-8.32%) during the most recent trading day.
- Over the past year, SPRY EV/EBITDA has dropped by -8.58 (-79.37%).
- SPRY EV/EBITDA is now -651.55% below its all-time high of -2.58.
Performance
SPRY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SPRY EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -8.3% | +8.4% | +8.1% |
| 1 m1 month | -5.2% | +5.2% | +5.0% |
| 3 m3 months | +5.1% | -5.1% | -4.9% |
| 6 m6 months | +12.8% | -0.7% | -0.7% |
| ytdytd | -16.6% | +16.6% | +16.0% |
| 1 y1 year | -79.4% | +60.9% | +50.4% |
| 5 y5 years | - | - | - |
SPRY EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -24.4% | -19.42 | +0.1% | |
| 3 m | 3-month | -15.39 | -26.0% | -23.28 | +16.7% |
| 6 m | 6-month | -15.39 | -26.0% | -28.24 | +31.3% |
| 1 y | 1-year | -10.81 | -79.4% | -28.24 | +31.3% |
| 3 y | 3-year | -2.58 | -651.5% | -28.24 | +31.3% |
| 5 y | 5-year | -2.58 | -651.5% | -28.24 | +31.3% |
| alltime | all time | -2.58 | -651.5% | -28.24 | +31.3% |
ARS Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -19.39(+16.6%) |
| 2024 | -16.63(+144.6%) |
| Date | Value |
|---|---|
| 2023 | -6.80(-59.6%) |
| 2022 | -16.82 |
FAQ
- What is ARS Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for ARS Pharmaceuticals?
- What is SPRY EV/EBITDA year-to-date change?
- What is ARS Pharmaceuticals EV/EBITDA year-on-year change?
What is ARS Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of SPRY is -19.39
What is the all time high EV/EBITDA for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high EV/EBITDA is -2.58
What is SPRY EV/EBITDA year-to-date change?
ARS Pharmaceuticals EV/EBITDA has changed by -2.76 (-16.60%) since the beginning of the year
What is ARS Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, SPRY EV/EBITDA has changed by -8.58 (-79.37%)